Thomas Garner has served as ACADIA's Executive Vice President and Chief Commercial Officer since December 2024, overseeing global commercial strategy for DAYBUE and NUPLAZID. He brings more than 25 years of pharmaceutical commercial experience. Before joining ACADIA he was Senior Vice President and Chief Commercial Officer at Lexicon Pharmaceuticals (2023-2024) and spent over 20 years at Bristol Myers Squibb, most recently as Senior Vice President and head of the U.S. Cardiovascular and Established Brands business unit and earlier as U.S. brand lead for Camzyos (mavacamten). He holds a BSc (Honors) from the Royal Agricultural University and a General Management certification from INSEAD.